ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cue Biopharma (CUE)

Technical Analysis Report for USA stock CUE Cue Biopharma. Dated: 10 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma

Cue Biopharma Opened at 0.29 and Closed at: 0.50, which is 42% of previous session's close. It moved within a range of 0.26 and 0.67
The session was a Bullish session with an average volume of 226121927, which is 95.36% of previous session's volumes.

    Support for tomorrow is 0.38 and resistance for tomorrow is 0.79
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 0.28, 0.07 resistance for tomorrow's hourly charts is 0.69, 0.89

    10 Day SMA for Cue Biopharma (CUE) is 0.25 and stock is trading above these levels. This is a good sign for its short term trend

    20 Day SMA for Cue Biopharma (CUE) is 0.26 and the stock is trading above these levels. This is a good sign for its mid term trend

    50 Day SMA for Cue Biopharma (CUE) is 0.29 and the stock is trading above these levels. This is a good sign for its mid to long term trend

    100 Day SMA is 0.36 and the stock is trading above these levels. This is a good sign for its long term trend

    200 Day SMA Cue Biopharma is 0.57 and stock is trading below these levels. This is not a good sign for its long term trend

    20 DMA of Cue Biopharma is at 0.26 and 200 DMA is at 0.57, while 50 DMA and 100 DMA are at 0.29 and 0.36 respectively

    Cue Biopharma (CUE) moving average of 20 SMA is at 0.26 and 20 EMA is at 0.26

    Cue Biopharma (CUE) moving average of 50 SMA is at 0.29 and 50 EMA is at 0.32

    Cue Biopharma (CUE) moving average of 100 SMA is at 0.36 and 100 EMA is at 0.44

    Cue Biopharma (CUE) moving average of 200 SMA is at 0.57 and 200 EMA is at 0.69

    Cue Biopharma has performed better than Elanco Animal in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Cardinal Health in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Bausch Health in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Savara Inc in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Sarepta Therapeutics in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Sellas Life in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Pavmed Inc in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Neurocrine Biosciences in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Lipocine Inc in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Ironwood Pharmaceuticals in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Inogen Inc in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Esperion Therapeutics in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Equillium Inc in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Cerus Corporation in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Biolinerx in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Atossa Genetics in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Accuray Incorporated in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Altimmune Inc in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma has performed better than Arsanis Inc in short term. Holding Cue Biopharma could be a better choice for now!

    Cue Biopharma Technical analysis of indicators

    Price action analysis of Cue Biopharma (CUE) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

    ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

    MACD generated a BUY signal for Cue Biopharma in short term but the buy signal is initial and weak.

    MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

    Cue Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

    Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

    CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.

    RSI is generating a BUY signal in short term and the buying is gaining momentum.

    MRSI is in negative zone. This is the SELL zone

    Although the stock is in the SELL zone, but selling might be slowing down

    Stock of Cue Biopharma is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 0.4 and Cue Biopharma CUE stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

    People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.

    Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And CUE Experts View which covers a lot of information including buying and selling signals

    CUE future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here

    Chart Cue Biopharma (CUE)  Technical (Analysis) Reports Cue Biopharma [

    Videos related to: Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

    Hindi Basics How To Trade In FnO Futures Options Stock Market

    Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

    Cue Biopharma (CUE)  Technical (Analysis) Reports Cue Biopharma [

     

    Back to top